Introduction
Medicinal chemists have directed significant efforts to the synthesis of nucleoside and nucleotide analogues endowed with antiviral and anticancer activities. [1] Their synthesis is not always straightforwarda nd often it is complicated by several issues, such us their poor solubility in organic solvents, the presenceo fseveral reactive functional groups, and the susceptibility of the glycosidicb ond to undergo hydrolytic cleavage. To overcome all these problems, different chemical strategies have been elaborated. Amongt hem,c hemical manipulation by means of protecting groups remains af undamental synthetic approacht op repare nucleoside analogues. Different protecting groups are commonly employed in nucleosidea nd nucleotide chemistry including both base and acid-labile. The triphenyl methyl group, most commonly indicated as the trityl group is typically used to protect selectively primary,o ver secondary hydroxyl functions.
[2] The positivec hargeo nt he alpha carbon,s tabilized by the resonance effect of three aromatic rings makes trityl ethers acid-labile. Since its discovery one hundred years ago, the trityl group has become ak ey protective group, widely used in nucleoside, oligonucleotide, peptide, carbohydrate chemistry,a nd indeedi na lmost all other fields of organica nd bioorganic chemistry.
[3] Typically,t he trityl group is introduced prior to manipulation of the structure and then removedw hen appropriate during the synthesis. However some recents tudies indicated that trityl-containing compounds themselves possess ac ertainb iological activity.T os ome degree, such discoveries may have been serendipitous. To the best of our knowledget he first account reporting on at rityl compound biologically active was in 2002 from Hernandez et al. [4] In their studies, 5'-O-tritylthymidine (1,F igure 1) emerges as an ovel inhibitor of human mitochondrial thymidine kinase. After that, several others tudies described the biological potentialofn ucleoside analogues bearing the trityl group. [5, 6] As eries of tritylated and dimethoxytritylated analogues of selected pyrimidine and purine nucleosides weres ynthesized and evaluatedf or their in vitro inhibitory activitya gainst two important members of the genus Flavivirus in the Flaviviridae family,t he yellow fever (YFV) and dengue viruses (DENV). Amonga ll compounds tested, the 5'-O-tritylated and the 5'-Odimethoxytritylated 5-fluorouridine derivativese xerted potency against YFV.I nterestingly in the series of purine analogues,t he 5'O, N-bis-tritylated fludarabine derivativer evealed strong inhibitory activity against DENV at mm concentrations, however significantly weaker potencya gainst YFV. In particular in 2013, De Burghgraeve et al. [7] duringt he screening of al arge compound library aimed at recognizing hit molecules, identified 2',5'-bis-O-tritylated uridine (2)asaflavivirus inhibitor.A saconsequence, severalo ther trityl uridine nucleosides, including different regioisomers, were prepared and evaluated in vitro against two important members of Flaviviridae family,y ellow fever (YFV) and dengue (DENV) viruses. [8] Amongt he different compounds 3',5'-bis-O-tritylated uridine (3)w as endowed with the best inhibitory properties (YFV IC 50 = 1.0 mm;D ENV IC 50 = 1.75 mm). [9] The finding of this lipophilic structure being endowed with high antiviral activity for flaviviruses, encouraged the same authors to undertake further research. However,m odifications of the trityl groups, combined with minor variations of the heterocyclic base generally led only to weak in vitro flavivirus inhibition and in some cases to marked in vitro cytotoxicity.F rom these studies, only 3',5'-bis-O-tritylated 5-fluoro-2'-deoxyuridine (4)s howed no cellular toxicityu pt oaconcentration of 25 mm,w hile having EC 50 values for YFV and DENV respectively of 1.05 mgmL À1 and 1.2 mgmL À1 . [6a] In the attempt to explain the mode of action of this class of compounds, De Burghgraeve et al. undertook further investigations. [7] Their preliminaryd ata suggested that the antiviral activity of this class of compounds might be due to an inhibition of the viral RNA-dependentR NA polymeraser ather than to am echanism interfering during an earlyo ralate stage of the viral life cyclesuch as virus entry,assembly,orr elease.
Despiteb eing under partial control, yellow fever case numbers are now increasing globally,p osingaseriousr isk of local epidemic outbreaks. The global incidence of dengue has also grown dramatically in recent decades. Both viruses are now considered globalt hreats for the entire word population. Althoughasafe and effective vaccine against YFV exists,t here is currently no vaccine availablef or dengue virus and its development has proven to be very difficult because of the existence of multiple serotypes. With no therapeutic agent available to treat and/or prevent severe epidemics of either yellow fever or dengue virus infections, prevention is currently limited to vector (mosquites) control measures.
[10] Therefore, there is an obvious and urgent need for the development of effective anti-flavivirus drugs. [11] Based on these considerations and the interesting data reported in the literature for the tritylated nucleosides, we becamei nterested in assessing the impact of the trityl group on several pyrimidine nucleosidesn ot included in the previous studies against both YFV andD ENV.
Ta king into account that in different studies, hindered nucleoside analogues (NAs) including 3',5'-O-trityl derivatives of adeninen ucleoside analoguesw eref ound to elicit anti-flavivirus activity to some extent, [6 g, 12] we decided to include also af ew selected purine analogues in our investigations.T he structures of the pyrimidine and purine nucleosides used in our studies are shown in Figure 2 .
Results and Discussion

Chemistry
Tritylation of nucleoside analogues has alwaysbeen ar elatively straightforward procedure. Generally,i ti ss ufficient to stir the selected nucleosides with an excess of trityl chloride at an elevated temperature (110 8C). [13] However some reports have shown that the temperature can be as low as 80-90 8C. For our synthesis, we followedt he mildera pproach reported by VanAerschot. [8] Briefly,t he selected nucleoside was treated in anhydrous pyridine, with an excesso ft rityl chloride (2.8 equivalents), and the resulting mixture heateda t8 0 8Cf or 18 h. After aqueous work-up, the desired tritylated compounds were isolated by column chromatography on silica gel. In order to avoid decompositiono ft he trityl moiety,0 .5 %o ft riethylamine was added to the chromatographic eluent in order to neutralize the silica gel acidity.A lthough this was not strictly necessary for trityl-bearing derivatives A-D (provided thatt heir purification was performed in ar easonablet ime), we found its use imperative during the purification of 4,4'-dimethoxytrityld erivatives (E-H). The reactiona lwaysr eturned compounds with ad iverse degree of tritylation (5'-, 3'-, and 2'-) depending upon the reactivity of the nucleoside. The differentr egioisomers were separated by column chromatography.T he general synthetic procedure for the preparation of the trityl ethers of these compounds is summarized in Scheme1,a nd complete compound information can be found in Ta ble1.
In ordert oe xpand the structure-activity relationship (SAR), and considering that flavivirus inhibition profile has been linked to the criticalr equirement of bulkiness in the region between the 3' and 5' positions [14] we decided to synthesize also the 4,4'-dimethoxytrityl derivatives (5-20 E-H,S cheme 2, Ta ble 2) of nucleosides 5-20.
5'-2'-O-Bis tritylated regioisomers were distinguished from those 5'-3'-O-bis tritylated analogues using 2D NMR experiments.C orrelation spectroscopy (COSY) analysis allowed the correct assignment of each protonfor all the compounds. Coupling of the OH signal to either the signal of 2' or 3' indicated which position is unalkylated.
Biological evaluation
The antiviral effect of all the parent nucleosides and their corresponding tritylated and 4,4'-dimethoxytritylated analogues was assessed using ac ell viability assay in whichV ero cells were infected with either yellow fever (YFV) or dengue viruses (DENV,s erotypeD 2) and further treated with the tested compounds at three different concentrations ( 5, 10, and 20 mm) . Cell viability was determined by measurement of the level of ATPpresentseven days post infection when compared to vehicle only (DMSO)c ontrols. [15] The resultsa re reporteda sp ercentage of viable cells left after the assay.T ables 3a nd 4g athered only compounds exhibiting an antiviral activity and include also their CC 50 values, defined as the concentration requiredt od ecrease cell growth by 50%. The toxicity of all the tested compounds on uninfected cells was also determined in parallel.
As expected, the parent nucleosides did not show any antiviral activity versus both the flaviviruses, considered in this study.
In the series of the tritylated nucleoside analogues two compounds:t he 5'-O-tritylated 5-FUR derivative (6D)a nd the 5'-Otritylated thymidine derivative (1)s howedasimilar protective However,a mong all the trityl analogues, the 5'-bis-O,N-tritylated derivative (20 D-NHTr)o ft he anticancer agent fludarabine (20)d isplayed the strongest anti-DENV inhibitory activity with 72 %o fv iable cells counted at 5 mm and 100 %a tb oth 10 mm and 20 mm.I nterestingly,t his compound, devoid of any significant anti-YFVinhibitory effect, seems to selectively target Table 1 . Summary of all synthesized tritylated compounds.
BCNA ( [a] Determined as an inhibition percentage of yellow fever (YFV, 17 Ds train of ASIBI) and dengue viruses (DENV,s erotype D2). Values are given as means AE SD for n = 3. RBV:r ibavirin, 5-FUR:5 -fluorouridine,5-IdU: 5-iodo-2'-deoxyuridine, 2'-FdU:2 '-fluoro-2'-deoxyuridine, 5-MeU: 5-methyluridine, PCV:penciclovir,OTr : O-trityl. ChemistryOpen 2016, 5,227 -235 www.chemistryopen.org DENV.D espite being the analogue of an anticancer agent, compound 20 D showed no cytotoxicity in our assays, up to a2 0mm. This noncytotoxic profile was observed also for all the other analogues considered in this work with no evidenceo ft oxicity at concentrationu pt o2 0mm.
Next, the antiviral effect of dimethoxytritylation of selected nucleoside analogues was evaluated similarly to the tritylated congeners against YF and DEN viruses.T able 4c ollects the result for the compounds of this series showing some antiviral activity.I np articulart he 5'-O-DMTr-FUR derivative( 6H), and, the 5'-O-DMTr-5-FUDR derivative (15 H)e merged as the most active compounds against YFV with 100 %i nhibition at 20 mm. Intriguing results were also found for the 5'-O-dimethoxytritylated-uridine analogue 9H,w hich showed inhibitory activity only against YFV with an inhibition of 1% at 5 mm;7 %a t 10 mm;and 100 %a t2 0mm.
All 4,4'-dimethoxytritylated compounds tested wered evoid of anti-DENV activity and were found to be not toxic at concentrationsupt o20 mm.
As mentioned already,c ompounds 3 and 2 have been previously reported as relatively potent anti-YFV and anti DENV agents.
[6] In contrast, our assays revealed no potency either as anti-YFVo ra nti-DENV agents. Explanation of the differing results from those reportedc ould be found in the differing detection methods used. [7] We assayed the metabolic activity of cells, quantitating ATP, which is rapidly degraded in dying cells. Using such an assay indicating active intracellularp rocesses, it is possible to dissect toxic and viral effectst hat lead to cells with intact membranes but no metabolic activity;t hat latter method( methylene blue dye exclusion) wasu sed in the prior reports. The ATPa ssay used here is more sensitive, indicates both toxic and viral effects leading to the loss of metabolic activity,a nd is the assay of choice to identify compounds, which lead to increased cell survival. [14, 15] 
Conclusion
We herein report the synthesis of tritylated and 4,4'-dimethoxytritylated pyrimidine and purinen ucleoside analogues and the evaluation of their inhibitory activity against YF and DEN viruses.T he activity was reported as %o fv iable cells resultingf rom treatment with our compounds after exposure to the viruses. In the series of 38 tritylated analogues, two compounds, 6D and 1,s howed selectivea nd moderateY FV inhibition (31 %a nd 26 %, respectively)a t2 0mm concentration. In the DENV inhibition assay, the tritylated fludarabine derivative 20 D-NHTr displayed pronounced anti-DENV inhibitory activity, reaching1 00 %o fv irus inhibition at ac oncentration of 10 mm. Within the panel of 16 4,4'-dimethoxytritylated compounds, five of the monosubstituted derivatives (6H,9 H, 12 H, 15 H, and 16 H)r evealed selectivea nti-YFV inhibitory activity ranging from 7t o9 5% at 10 mm and from 70 to 100 %a t2 0mm.A ll the tested compounds proved to be noncytotoxic at concentrationsupt o20 mm.
In conclusion, our preliminaryb iological data support an anti-flavivirus activity for tritylated/4,4'-dimethoxytritylated nucleoside analogues. Previous studies have suggested that these drugs might act as potentiali nhibitors of the DENV viral RNA-dependent RNA polymerase (RdRp). [7] However,e vidence to unravel their mechanism of action have not been provided yet. In fact, their structure-activity relationship remains unclear and requires additional studies and therefore it is not possible for us here to speculateo napossible mechanism. It might be however that the prior identified lead impacted on cellular metabolic processes rather than aviral target.
Experimental Section Generale xperimental
All solvents and reagents were used as obtained from commercial sources unless otherwise indicated. All reactions were performed under an argon atmosphere. The 1 Ha nd 13 CNMR spectra were recorded on aB ruker spectrometer (Billerica, MA, USA) operating at 500 MHz for [a] Determined as an inhibition percentageo fy ellow fever( YFV, 17D strain of ASIBI) and dengue viruses (DENV, serotype D2).V alues are given as means AE SD for n = 3. 5-FUR:5 -fluorouridine, 3TC:l amivudine, 5-FUDR: 5-fluoro-2'-deoxyuridine, 2'-FdU:2'-fluoro-2'-deoxyuridine. ChemistryOpen 2016, 5,227 -235 www.chemistryopen.org spectra (MS) were measured in positive-mode electrospray ionization (ESI). Thin-layer chromatography (TLC) was performed on silica gel 60 F254 plastic sheets. Column chromatography was performed using silica gel (35-75 mesh) or on an Isolera Biotage system (Uppsala, Sweden). Purity of prepared compounds was determined to be > 95 %b yh igh-performance liquid chromatography (HPLC)-UV analysis (Thermo HPLC connected with UV detector; Varian Pursuit XS, 4.6 mm 150 mm, 5.0 mm, Palo Alto, CA, USA).
Chemistry
General Procedure 1.Am ixture of an ucleoside (1.0 eq mol À1 ), an appropriate trityl chloride (2.2 eq mol À1 ), and 4-dimethylaminopyridine (DMAP,2 .8 mol eq À1 ,u nless stated otherwise) in anhydrous pyridine (4.5 mL mmol À1 )w as heated at 80 8Cu nder an argon atmosphere for 18 h. The reaction was quenched by addition of MeOH (2 mL mmol À1 )a tr t, and kept stirring at rt for 30 min. The solution was then concentrated and diluted in CH 2 Cl 2 .T he organic solution was washed with saturated solution of NaHCO 3 (3 20 mL), and the combined aqueous layers were extracted with CH 2 Cl 2 .C ombined organic layers were dried over Na 2 SO 4 ,f iltered, and concentrated under vacuum. The residue was purified by column chromatography on silica gel (eluent system gradient MeOH in CH 2 Cl 2 = 1-3 %containing 0.5 %triethylamine).
Experimental data for all active compounds are reported below and for inactive compounds in the Supporting Information.
Tritylated derivatives of ribavirin (5) C-3) , 143.5, 128.7, 128.6, 128.3, 127.8, Dimethoxytritylated derivatives of 5-fluorouridine (6)w ere prepared according to the general procedure 1f rom 6 (0.30 g, 1.14 mmol) and 4,4'-dimethoxytrityl chloride (1.24 g, 3.66 mmol, 3.2 equiv/mol) in pyridine (6 mL). Column chromatography purification using ag radient of MeOH/triethylamine (1:0.5 %t o2:0.5 %) in CH 2 Cl 2 as an eluent yielded three products, which were further repurified by preparative TLC using MeOH/triethylamine (2:0.5 %) in CH 2 Cl 2 to yield:5 ',3'-bis-O-dimethoxytrityl-5fluorouridine (6F), 5',2'-bis-O-dimethoxytrityl-5-fluorouridine (6 G),a nd 5'-O-dimethoxytrityl-5-fluorouridine (6H). 130.3, 130.2, 130.1, 129.2, 128.1, 127.9, 127.8, 127.1, 113.4, 113.3, , 90.6 (C-1'), 83.8 (C-4'), 87.0 (C(Ph) 3 ), 75.5 (C-2'), 69.7 (C-3'), 61.9 (C-5'), 55. Column chromatography with ag radient of MeOH/triethylamine ChemistryOpen 2016, 5,227 -235 www.chemistryopen.org
(1:0.5 %t o2:0.5 %) in CH 2 Cl 2 as an eluent yielded 12 H as aw hite solid (0.55 g, 33 %); 1 HNMR (500 MHz, 25 8C, CDCl 3 ): d = 9.73 (bs, 1H,N H), 8.43 (d, J = 7.5 Hz, 1H, 2H, 7H, 7.21 (d, J = 7.5 Hz, 4H, 8.16 (s, 1H, 6H, 6H, 3H, 6.34 (dd, J = 6.0, 8.0 Hz, 1H, 1H, 1H, 2H, , 2.56-2.52 (m, 1H, H-2'a), 2.32-2.28 ppm (m, 1H, H-2'b); Dimethoxytritylated derivatives of 5-fluoro-2'deoxyuridine (15) were prepared according to the general procedure 1f rom 15 (0.30 g, 1.22 mmol) and 4,4'-dimethoxytrityl chloride (0.90 g, 2.68 mmol) in pyridine (6 mL). Column chromatography purification using gradient of MeOH/triethylamine (1:0.5 %t o2 :0.5 %) in CH 2 Cl 2 as an eluent followed by preparative TLC purification with MeOH/triethylamine (2:0.5 %) in CH 2 Cl 2 yielded 5',3'-bis-O-dimethoxytrityl-5-fluoro-2'-deoxyuridine (15 F)a nd 5'-O-dimethoxytrityl-5-fluoro-2'-deoxyuridine (15 H). Tritylated derivatives of 2'-fluoro-2'-deoxyuridine (16)w ere prepared according to the general procedure 1f rom 16 (0.50 g, 2.03 mmol) and trityl chloride (1.60 g, 5. 69 mmol) in anhydrous pyridine (10 mL). After work-up, the crude sample was purified by column chromatography using gradient of MeOH/triethylamine (1:0.5 %t o2 .5:0.5 %) in CH 2 Cl 2 to give 5',3'-bis-O-trityl-2'-fluoro-2'-deoxyuridine 16 B and 5'-O-trityl-2'-fluoro-2'-deoxyuridine 16 D. 
